Metraipolis › archive › dc_b200d9aa60da
Dose differences between patients treated with MR-only, CT-only, or MR-CT fusion radiotherapy for prostate cancer — Europe PMC PMID:40668761
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40668761
- DOI
- 10.1093/bjr/tqaf159
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T03:33:08.219Z
- SHA-256 of the archived text
612aa347e6716074b5b13cd259b363d04a55e139332a8c907b4f66503306bc69- Stable URL of this page
https://metraipolis.com/documento/dc_b200d9aa60da
How to cite
Dose differences between patients treated with MR-only, CT-only, or MR-CT fusion radiotherapy for prostate cancer — Europe PMC PMID:40668761 — Europe PMC (en), https://europepmc.org/article/MED/40668761 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b200d9aa60da (Metraipolis archive dc_b200d9aa60da, sha256 612aa347e6716074b5b13cd259b363d04a55e139332a8c907b4f66503306bc69)
BibTeX
@misc{dcb200d9aa60da,
title = {Dose differences between patients treated with MR-only, CT-only, or MR-CT fusion radiotherapy for prostate cancer — Europe PMC PMID:40668761},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40668761},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b200d9aa60da; sha256 612aa347e6716074b5b13cd259b363d04a55e139332a8c907b4f66503306bc69},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40668761. Agents can read the archived copy with the MCP tool read_document.